FindTrial
Sign In

A Clinical and Multimodal Assessment of Improvement in Cognitive Impairment in Children with ADHD Using Methylphenidate

Improvement in cognitive impairment in children with ADHD following methylphenidate treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110111
Enrollment
Unknown
Registered
2025-09-30
Start date
2024-01-27
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ADHD

Interventions

ADHD:Oral methylphenidate

Sponsors

West China Second Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 14 Years

Inclusion criteria

Inclusion criteria: 1 Fulfilment of the corresponding ADHD diagnostic criteria in DSM-V; 2 Age 6 to 14 years old; 3 A total IQ score of >= 80 on the Wechsler Intelligence Scale for Children; 4 Not receiving ADHD-related medication; 5 The children and their parents agreed to participate in the study.

Exclusion criteria

Exclusion criteria: 1 An intelligence test score below 80; 2 Previous history of severe traumatic brain injury and brain damage; 3 Mental disorders such as schizophrenia, bipolar disorder and depressed patients; 4 Comorbid autism spectrum disorders and language disorders;

Design outcomes

Primary

MeasureTime frame
SNAP-IV Rating Scale;IVA-2 Audiovisual Integration Attention Test;Wisconsin Picture Test;Stroop Color Word Naming Test;go/no-go behavioral indicators;fNIRS brain region oxyhemoglobin concentration;—

Secondary

MeasureTime frame
Weiss Functional Deficits Scale;Conners Scale;—

Countries

China

Contacts

Public ContactZhou hui

West China Second Hospital, Sichuan University

1103570489@qq.com+86 181 8060 9239

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026